Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years

References

• Browne S, Feemster KA. Human papillomavirus: optimizing opportunities for prevention. Curr Opin Pediatr. 2022;34(2):132–8. doi:10.1097/MOP.0000000000001119.
   PubMed Web of Science ®Google Scholar
• Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis. 2014;41(11):660–664. doi:10.1097/OLQ.0000000000000193.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1–24.
   PubMedGoogle Scholar
• Pauli S, Kops NL, Bessel M, Lina Villa L, Moreno Alves Souza F, Mendes Pereira GF, Neves Hugo F, Comerlato J, Bandeira I, Fernandes B, et al. Sexual practices and HPV infection in unvaccinated young adults. Sci Rep. 2022;12(1):12385. doi:10.1038/s41598-022-15088-8.
   Web of Science ®Google Scholar
• Osazuwa-Peters N, Simpson MC, Rohde RL, Challapalli SD, Massa ST, Adjei Boakye E. Differences in sociodemographic correlates of human papillomavirus-associated cancer survival in the United States. Cancer Control. 2021;28:10732748211041894. doi:10.1177/10732748211041894.
   Web of Science ®Google Scholar
• Osazuwa-Peters N, Simpson MC, Massa ST, Adjei Boakye E, Antisdel JL, Varvares MA. 40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States. Oral Oncol. 2017;74:90–97. doi:10.1016/j.oraloncology.2017.09.015.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–4301. doi:10.1200/JCO.2011.36.4596.
   PubMed Web of Science ®Google Scholar
• Ellington TD, Henley SJ, Senkomago V, O’Neil ME, Wilson RJ, Singh S, Thomas CC, Wu M, Richardson LC. Trends in incidence of cancers of the oral cavity and pharynx—United States 2007–2016. MMWR Morb Mortal Wkly Rep. 2020;69(15):433. doi:10.15585/mmwr.mm6915a1.
   PubMed Web of Science ®Google Scholar
• Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33(29):3235–42. doi:10.1200/JCO.2015.61.6995.
   PubMed Web of Science ®Google Scholar
• Guo T, Eisele DW, Fakhry C. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer. 2016;122(15):2313–2323. doi:10.1002/cncr.29992.
   PubMed Web of Science ®Google Scholar
• Osazuwa-Peters N. Human Papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States–do we need a broader vaccine policy? Vaccine. 2013;31(47):5500–5. doi:10.1016/j.vaccine.2013.09.031.
   PubMed Web of Science ®Google Scholar
• Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Use of 9-valent Human Papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300–4.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration (FDA). FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old.
   Google Scholar
• Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698–702. doi:10.15585/mmwr.mm6832a3.
   PubMed Web of Science ®Google Scholar
• Lewis RM, Markowitz LE, Gargano JW, Steinau M, Unger ER. Prevalence of genital human papillomavirus among sexually experienced males and females aged 14–59 years, United States, 2013–2014. J Infect Dis. 2018;217(6):869–77. doi:10.1093/infdis/jix655.
   PubMed Web of Science ®Google Scholar
• King LM, Lewnard JA, Niccolai LM. Clinical and public health considerations for HPV vaccination in midadulthood: a narrative review. Open Forum Infect Dis. 2023;10(1). doi:10.1093/ofid/ofad004.
   Web of Science ®Google Scholar
• Suk R, Liao K, Bauer CX, Basil C, Li M. Human papillomavirus vaccine administration trends among commercially insured US adults aged 27-45 years before and After Advisory Committee on Immunization Practices Recommendation Change, 2007–2020. JAMA Health Forum. 2022;3:e224716. doi:10.1001/jamahealthforum.2022.4716.
   Google Scholar
• Thompson EL, Garg A, Galvin AM, Moore JD, Kasting ML, Wheldon CW. Correlates of HPV vaccination intentions among adults ages 27-45 years old in the U.S. J Commun Health. 2021;46(5):893–902. doi:10.1007/s10900-021-00968-3.
   Web of Science ®Google Scholar
• Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Approaching a decade since HPV vaccine licensure: racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Hum Vaccin Immunother. 2017;13(11):2713–2722. doi:10.1080/21645515.2017.1363133.
   PubMed Web of Science ®Google Scholar
• Thompson EL, Wheldon CW, Rosen BL, Maness SB, Kasting ML, Massey PM. Awareness and knowledge of HPV and HPV vaccination among adults ages 27–45 years. Vaccine. 2020;38(15):3143–8. doi:10.1016/j.vaccine.2020.01.053.
   PubMed Web of Science ®Google Scholar
• Stephens ES, Dema E, McGee-Avila JK, Shiels MS, Kreimer AR, Shing JZ. Human papillomavirus awareness by educational level and by race and ethnicity. JAMA Netw Open. 2023;6(11):e2343325. doi:10.1001/jamanetworkopen.2023.43325.
   Web of Science ®Google Scholar
• Le D, Kim HJ, Wen KY, Juon HS. Disparities in awareness of the HPV vaccine and HPV-associated cancers among racial/ethnic minority populations: 2018 HINTS. Ethn Health. 2023;28(4):586–600. doi:10.1080/13557858.2022.2116630.
   PubMed Web of Science ®Google Scholar
• Abouelella DK, Canick JE, Barnes JM, Rohde RL, Watts TL, Adjei Boakye E, Osazuwa-Peters N. Human papillomavirus vaccine uptake among teens before and during the COVID-19 pandemic in the United States. Hum Vaccines Immunother. 2022;18(7):2148825. doi:10.1080/21645515.2022.2148825.
   Google Scholar
• Francis JKR, Weerakoon SM, Lucas SL, Mathew MS, Durante JC, Kelly N, Tiro JA. Human papillomavirus vaccination before and during the COVID-19 pandemic. JAMA Netw Open. 2022;5(9):2234000. doi:10.1001/jamanetworkopen.2022.34000.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). National center for health statistics. National Health Interview Survey; [accessed 2023 Mar 28]. https://www.cdc.gov/nchs/nhis/about_nhis.htm.
   Google Scholar
• Brotherton JM, Zuber PL, Bloem PJ. Primary prevention of HPV through vaccination: update on the current global status. Curr Obstet Gynecol Rep. 2016;5(3):210–224. doi:10.1007/s13669-016-0165-z.
   Google Scholar
• Razzaghi H, Saraiya M, Thompson TD, Henley SJ, Viens L, Wilson R. Five-year relative survival for human papillomavirus-associated cancer sites. Cancer. 2018;124(1):203–211. doi:10.1002/cncr.30947.
   PubMed Web of Science ®Google Scholar
• Osazuwa-Peters N, Massa ST, Simpson MC, Adjei Boakye E, Varvares MA. Survival of human papillomavirus-associated cancers: filling in the gaps. Cancer. 2018;124(1):18–20. doi:10.1002/cncr.30945.
   PubMed Web of Science ®Google Scholar
• Berwick DM. Disseminating innovations in health care. JAMA. 2003;289(15):1969–1975. doi:10.1001/jama.289.15.1969.
   PubMed Web of Science ®Google Scholar
• Brownson RC, Fielding JE, Maylahn CM. Evidence-based public health: a fundamental concept for public health practice. Annu Rev Public Health. 2009;30(1):175–201. doi:10.1146/annurev.publhealth.031308.100134.
   PubMedGoogle Scholar
• Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Williams CL, Fredua B, McNamara LA, Stokley S, Singleton JA. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(35):1183. doi:10.15585/mmwr.mm7035a1.
   PubMed Web of Science ®Google Scholar
• Osazuwa-Peters N, Adjei Boakye E, Mohammed KA, Tobo BB, Geneus CJ, Schootman M. Not just a woman’s business! Understanding men and women’s knowledge of HPV, the HPV vaccine, and HPV-associated cancers. Prev Med. 2017;99:299–304. doi:10.1016/j.ypmed.2017.03.014.
   PubMed Web of Science ®Google Scholar
• Daley EM, Vamos CA, Thompson EL, Zimet GD, Rosberger Z, Merrell L, Kline NS. The feminization of HPV: how science, politics, economics and gender norms shaped U.S. HPV vaccine implementation. Papillomavirus Res (Amsterdam, Netherlands). 2017;3:142–8. doi:10.1016/j.pvr.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Osazuwa-Peters N, Wang DD, Namin A, John VM, O’Neill M, Patel PV, Varvares MA. Sexual behavior, HPV knowledge, and association with head and neck cancer among a high-risk group. Oral Oncol. 2015;51(5):452–6. doi:10.1016/j.oraloncology.2015.01.011.
   Web of Science ®Google Scholar
• Osazuwa-Peters N, Adjei Boakye E, Chen BY, Clancy J, Vallot PL, Su JL, Beck GE, Varvares MA. Sociodemographic factors associated with knowledge and risk perception of human papillomavirus and human papillomavirus–associated oropharyngeal squamous cell carcinoma among a predominantly Black population. JAMA Otolaryngol Head Neck Surg. 2017;143(2):117–24. doi:10.1001/jamaoto.2016.2784.
   Web of Science ®Google Scholar
• Kasting ML, Giuliano AR, Christy SM, Rouse CE, Robertson SE, Thompson EL. Human papillomavirus vaccination prevalence among adults aged 19–45 years: an analysis of the 2017 national health interview survey. Am J Prev Med. 2020;59(6):837–49. doi:10.1016/j.amepre.2020.05.031.
   Web of Science ®Google Scholar
• Daniel-Ulloa J, Gilbert PA, Parker EA. Human papillomavirus vaccination in the United States: uneven uptake by gender, race/ethnicity, and sexual orientation. Am J Public Health. 2016;106(4):746–747. doi:10.2105/AJPH.2015.303039.
   PubMed Web of Science ®Google Scholar
• De P, Budhwani H. Human Papillomavirus (HPV) vaccine initiation in minority Americans. Pub Health. 2017;144:86–91. doi:10.1016/j.puhe.2016.11.005.
   PubMed Web of Science ®Google Scholar
• Adjei Boakye E, Zeng W, Governor S, Nagendra S, Tobo BB, Simpson MC, Osazuwa-Peters N. Differences in Human Papillomavirus (HPV) vaccine uptake by nativity status among men aged 18–34 years. Prev Med Rep. 2019;16:101010. doi:10.1016/j.pmedr.2019.101010.
   PubMedGoogle Scholar
• Ashing KT, Carrington A, Ragin C, Roach V. Examining HPV- and HPV vaccine-related cognitions and acceptability among US-born and immigrant hispanics and US-born and immigrant Non-Hispanic Blacks: a preliminary catchment area study. Cancer Causes Control. 2017;28(11):1341–1347. doi:10.1007/s10552-017-0973-0.
   PubMed Web of Science ®Google Scholar
• Lee HY, Luo Y, Neese J, Daniel C, Hahm HC. The role of English proficiency in HPV and HPV vaccine awareness: a cross-sectional study across race/ethnicity. Asian Pac J Cancer Prev. 2021;22(2):349–357. doi:10.31557/APJCP.2021.22.2.349.
   Google Scholar
• Ashing KT, Chávez NR, Serrano M. HPV vaccine-related knowledge, beliefs, acceptability, and uptake among Latinas who prefer English and those who prefer Spanish. J Health Commun. 2016;21(12):1209–16. doi:10.1080/10810730.2016.1240266.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. Strategic plan FY 2022-2026. Strategic goal 1: protect and strengthen equitable access to high quality and affordable healthcare. https://www.hhs.gov/about/strategic-plan/2022-2026/goal-1/index.html#:~:text=Increasing%20choice%2C%20affordability%20and%20enrollment,safe%20medical%20devices%20and%20drugs.
   Google Scholar
• U.S. Department of Health and Human Services. Office of disease prevention and health promotion. Healthy People 2030. Objectives. https://health.gov/healthypeople/objectives-and-data/browse-objectives#settings-and-systems.
   Google Scholar
• Lu PJ, O’Halloran A, Williams WW, Lindley MC, Farrall S, Bridges CB. Racial and ethnic disparities in vaccination coverage among adult populations in the U.S. Am J Prev Med. 2015;49(6 Suppl 4):S412–425. doi:10.1016/j.amepre.2015.03.005.
   PubMed Web of Science ®Google Scholar
• Sonawane K, Zhu Y, Montealegre JR, Lairson DR, Bauer C, McGee LU, Giuliano AR, Deshmukh AA. Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey. Lancet Public Health. 2020;5(9):484–92. doi:10.1016/S2468-2667(20)30139-0.
   PubMed Web of Science ®Google Scholar
• Wheldon CW, Garg A, Galvin AM, Moore JD, Thompson EL. Decision support needs for shared clinical decision-making regarding HPV vaccination among adults 27-45 years of age. Patient Educ Couns. 2021;104(12):3079–85. doi:10.1016/j.pec.2021.04.016.
   PubMed Web of Science ®Google Scholar
• Adjei Boakye E, Nair M, Abouelella DK, Joseph CLM, Gerend MA, Subramaniam DS, Osazuwa-Peters N. Trends in reasons for human papillomavirus vaccine hesitancy: 2010–2020. Pediatrics. 2023;151(6). doi:10.1542/peds.2022-060410.
   Web of Science ®Google Scholar
• Galvin AM, Garg A, Griner SB, Moore JD, Thompson EL. Health literacy correlates to HPV vaccination among US adults ages 27-45. J Cancer Educ. 2023;38(1):349–56. doi:10.1007/s13187-021-02123-x.
   Web of Science ®Google Scholar
• Alaraj RA, Brown B, Polonijo AN. “If people were told about the cancer, they’d want to get vaccinated”: knowledge, attitudes, and beliefs about HPV vaccination among mid-adult men. Am J Men’s Health. 2023;17(1):15579883231153310. doi:10.1177/15579883231153310.
   Web of Science ®Google Scholar
• Deshmukh AA, Suk R, Shiels MS, Sonawane K, Nyitray AG, Liu Y, Gaisa MM, Palefsky JM, Sigel K. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001–2015. J Natl Cancer Inst. 2020;112(8):829–38. doi:10.1093/jnci/djz219.
   PubMedGoogle Scholar
• Liao CI, Francoeur AA, Kapp DS, Caesar MAP, Huh WK, Chan JK. Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001–2017. JAMA Netw Open. 2022;5(3):e222530. doi:10.1001/jamanetworkopen.2022.2530.
   PubMed Web of Science ®Google Scholar
• Xu L, Dahlstrom KR, Lairson DR, Sturgis EM. Projected oropharyngeal carcinoma incidence among middle-aged US men. Head Neck. 2019;41(9):3226–3234. doi:10.1002/hed.25810.
   PubMed Web of Science ®Google Scholar